Sources | Names Used |
---|---|
CTRPv2 | BRD-K09587429 |
PharmacoGx | BRD-K09587429 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF273 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
mRNA | SFT2D1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
mRNA | NPHP3-ACAD11 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
mRNA | C17orf107 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
mRNA | TBC1D32 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
mRNA | FANCE | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
mRNA | ANTXR1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |
mRNA | WDR38 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
mRNA | PHF20L1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
mRNA | CAPN15 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |